1. Home
  2. RGEN vs CIGI Comparison

RGEN vs CIGI Comparison

Compare RGEN & CIGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • CIGI
  • Stock Information
  • Founded
  • RGEN 1981
  • CIGI 1972
  • Country
  • RGEN United States
  • CIGI Canada
  • Employees
  • RGEN N/A
  • CIGI N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • CIGI
  • Sector
  • RGEN Health Care
  • CIGI
  • Exchange
  • RGEN Nasdaq
  • CIGI Nasdaq
  • Market Cap
  • RGEN 8.0B
  • CIGI 6.8B
  • IPO Year
  • RGEN N/A
  • CIGI N/A
  • Fundamental
  • Price
  • RGEN $121.74
  • CIGI $142.37
  • Analyst Decision
  • RGEN Buy
  • CIGI Buy
  • Analyst Count
  • RGEN 12
  • CIGI 7
  • Target Price
  • RGEN $168.40
  • CIGI $160.33
  • AVG Volume (30 Days)
  • RGEN 759.3K
  • CIGI 126.7K
  • Earning Date
  • RGEN 07-29-2025
  • CIGI 07-31-2025
  • Dividend Yield
  • RGEN N/A
  • CIGI 0.21%
  • EPS Growth
  • RGEN N/A
  • CIGI 38.82
  • EPS
  • RGEN N/A
  • CIGI 2.86
  • Revenue
  • RGEN $650,429,000.00
  • CIGI $4,961,214,000.00
  • Revenue This Year
  • RGEN $14.06
  • CIGI $13.69
  • Revenue Next Year
  • RGEN $14.33
  • CIGI $6.68
  • P/E Ratio
  • RGEN N/A
  • CIGI $49.70
  • Revenue Growth
  • RGEN 4.88
  • CIGI 13.50
  • 52 Week Low
  • RGEN $102.97
  • CIGI $100.86
  • 52 Week High
  • RGEN $182.52
  • CIGI $156.96
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 48.77
  • CIGI 73.15
  • Support Level
  • RGEN $116.30
  • CIGI $137.64
  • Resistance Level
  • RGEN $125.00
  • CIGI $142.50
  • Average True Range (ATR)
  • RGEN 5.00
  • CIGI 3.34
  • MACD
  • RGEN -0.32
  • CIGI 0.51
  • Stochastic Oscillator
  • RGEN 44.03
  • CIGI 96.84

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About CIGI Colliers International Group Inc. Subordinate Voting Shares

Colliers International Group Inc provides commercial real estate professional services and investment management to corporate and institutional clients across different countries around the world. Its operating segments are; Real Estate Services, Engineering, Investment Management, and Corporate. Maximum revenue for the company is generated from its Real Estate Services segment, which offers services like transaction and debt finance services, outsourcing in property management, valuation and advisory, loan servicing, property sales brokerage, and lease brokerage services, among others. Geographically, the company generates maximum revenue from the United States and the rest from Canada, Australia, the United Kingdom, Poland, China, India, and other regions.

Share on Social Networks: